LOVFF (Cannara Biotech) Inventory Turnover: 0.30 (As of Feb. 2026)

What is Cannara Biotech Inventory Turnover?

Cannara Biotech LOVFF +5.93% 86 Inventory Turnover is 0.30 as of Feb. 2026. GuruFocus rates LOVFF with a GF Score™ of 86/100 and a GF Value™ of $1.17 (Fairly Valued). The stock has 4 warning signs investors should review.

Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. Cannara Biotech's Cost of Goods Sold for the three months ended in Feb. 2026 was $11.38 Mil. Cannara Biotech's Average Total Inventories for the quarter that ended in Feb. 2026 was $38.32 Mil. Cannara Biotech's Inventory Turnover for the quarter that ended in Feb. 2026 was 0.30.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Cannara Biotech's Days Inventory for the three months ended in Feb. 2026 was 307.33.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Cannara Biotech's Inventory-to-Revenue for the quarter that ended in Feb. 2026 was 1.92.

Cannara Biotech (OTCPK:LOVFF) Inventory Turnover Explanation

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Cannara Biotech's Days Inventory for the three months ended in Feb. 2026 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Feb. 2026 )	/	Cost of Goods Sold (Q: Feb. 2026 )	*	Days in Period
	=	38.3245	/	11.379	*	365 / 4
	=	307.33

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Cannara Biotech's Inventory to Revenue for the quarter that ended in Feb. 2026 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Feb. 2026 )	/	Revenue (Q: Feb. 2026 )
	=	38.3245	/	19.914
	=	1.92

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.

Cannara Biotech Inventory Turnover Related Terms

Cannara Biotech Inventory Turnover Historical Data

* Premium members only.

The historical data trend for Cannara Biotech's Inventory Turnover can be seen below:

Cannara Biotech Inventory Turnover Chart

Cannara Biotech Annual Data

Trend

Aug18

Aug19

Aug20

Aug21

Aug22

Aug23

Aug24

Aug25

Inventory Turnover

Get a 7-Day Free Trial

1.41

1.39

1.12

1.40

1.31

Cannara Biotech Quarterly Data
	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24	Nov24	Feb25	May25	Aug25	Nov25	Feb26
Inventory Turnover	Get a 7-Day Free Trial															0.33	0.31	0.32	0.36	0.30

86GF Score

Cannara Biotech Inc LOVFF

Inventory Turnover is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Cannara Biotech Inventory Turnover Calculation

Cannara Biotech's Inventory Turnover for the fiscal year that ended in Aug. 2025 is calculated as

	Inventory Turnover (A: Aug. 2025 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (A: Aug. 2025 )	/ (	(Total Inventories (A: Aug. 2024 )	+	Total Inventories (A: Aug. 2025 ))	/	count )
=	43.56	/ (	(29.347	+	37.205)	/	2 )
=	43.56	/	33.276
=	1.31

Cannara Biotech's Inventory Turnover for the quarter that ended in Feb. 2026 is calculated as

	Inventory Turnover (Q: Feb. 2026 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (Q: Feb. 2026 )	/ (	(Total Inventories (Q: Nov. 2025 )	+	Total Inventories (Q: Feb. 2026 ))	/	count )
=	11.379	/ (	(36.971	+	39.678)	/	2 )
=	11.379	/	38.3245
=	0.30

Frequently Asked Questions Learn more about Inventory Turnover →

What does a Inventory Turnover of 0.30 mean?

Cannara Biotech (LOVFF) has a Inventory Turnover of 0.30 as of Feb. 2026. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on Cannara Biotech and its competitors.

Is Cannara Biotech's Inventory Turnover too high?

Cannara Biotech's current Inventory Turnover is 0.30. Overall, Cannara Biotech has a GF Score™ of 86/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.

How does Cannara Biotech's Inventory Turnover compare to ZTS and UTHR?

Cannara Biotech's Inventory Turnover of 0.30 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Inventory Turnover for a Drug Manufacturers company?

A good Inventory Turnover depends on the Drug Manufacturers industry context. However, Inventory Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Inventory Turnover mean?

A high Inventory Turnover can signal that a stock is expensive relative to its fundamentals. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on Cannara Biotech and its competitors. Cannara Biotech's current Inventory Turnover is 0.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Cannara Biotech stock overvalued right now?

Based on GuruFocus' analysis, Cannara Biotech (LOVFF) is currently considered Fairly Valued. The stock's GF Value™ is $1.17, compared to a current price of $1.25 — trading 6.8% above its estimated fair value. The current Inventory Turnover is 0.30. Cannara Biotech's overall GF Score™ is 86/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Inventory Turnover calculated?

Inventory Turnover is calculated from a company's financial statements. For Cannara Biotech (LOVFF), the current Inventory Turnover is 0.30 as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cannara Biotech (LOVFF) Overvalued in 2026?

Based on GuruFocus' analysis, Cannara Biotech stock appears to be overvalued. The current stock price of $1.25 is trading 6.8% above its estimated GF Value™ of $1.17. GuruFocus considers Cannara Biotech to be Fairly Valued.

Key valuation signals for LOVFF:

Inventory Turnover: 0.30
GF Value™: $1.17 vs. price of $1.25 (6.8% above fair value)
GF Score™: 86/100 with 4 warning signs

No single metric tells the full story. See the LOVFF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cannara Biotech Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies TSXV:RX TSX:CRDL XCNQ:GRIN XCNQ:AAWH.U XCNQ:JUSH TSX:MDP TSX:HLS TSX:OGI TSX:CWEB XCNQ:NVRS XTER:MRK XSWX:GALD TSE:4502 SHSE:600276 NSE:SUNPHARMA LSE:HLN XTAE:TEVA XSWX:SDZ ZTS UTHR

Other Exchanges 8CB0:Germany LOVE:Canada

Address 1055 West Georgia Street, Suite 2050, Vancouver, BC, CAN, V6E 3P3

Website http://www.cannara.ca

Cannara Biotech Inc is a vertically integrated producer of premium-grade cannabis and cannabis-derivative products for Canadian markets. The company owns two mega Quebec-based facilities. The company operates in in two segments; Indoor cannabis operations segment which includes the cultivation, processing and sale of dried cannabis and cannabis derivatives for the Canadian market and the Real estate operations segment related to the Farnham and Valleyfield building. Majority of the revenue for the company is generated from its Cannabis operations segment. .

86GF Score

Get the complete analysis for LOVFF

Inventory Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.25

Price

$1.17

GF Value

View LOVFF Analysis

See Inventory Turnover data for all stocks →